Mint Tower Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17
Closed -$1.25K 369
2020
Q4
$1K Sell
17
-434
-96% -$33.2K ﹤0.01% 279
2020
Q3
$36K Sell
451
-42
-9% -$3.29K ﹤0.01% 233
2020
Q2
$36K Sell
493
-1,191
-71% -$89.7K ﹤0.01% 232
2020
Q1
$124K Buy
+1,684
New +$132K 0.02% 194
2019
Q1
Sell
-6,707
Closed -$502K 232
2018
Q4
$489K Buy
+6,707
New +$473K 0.06% 139

Other funds holding MRK

Mint Tower Capital Management's MRK Position: Q1 2021 in Review

Mint Tower Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 17 shares — an estimated $1.25K sold.

Mint Tower Capital Management first reported a position in MRK in Q4 2018 and held it in 5 quarters. The position peaked at $489K in Q4 2018. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Mint Tower Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 17 Merck shares in Q1 2021, an estimated $1.25K.
  • Mint Tower Capital Management first reported a position in Merck in Q4 2018 and held it in 5 quarters.
  • Mint Tower Capital Management's Merck position peaked at $489K in Q4 2018.
  • 2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Mint Tower Capital Management's 13F filing for Q1 2021, filed 12 May 2021.